Author

Djordje O. Gveric

Imperial College LondonORCID 0000-0003-1954-4983Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Javier Alegre‐AbarrateguiiD· 2 shared Maria Otero‐JimeneziD· 2 shared Steve GentlemaniD· 2 shared Alexander HaglundiD· 1 shared Alexi NottiD· 1 shared Alyma Somani· 1 shared Amy M. SmithiD· 1 shared Ann C. BabtieiD· 1 shared

Activity by Year

2022-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Javier Alegre‐AbarrateguiORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

NeuroscienceBrain PathologyPeer-reviewedAug 30, 2026

Olfactory proteomics reveals the capacity of the HDAC1 inhibitor pyroxamide to halt the α-synuclein preformed fibrils-induced damage in nasal epithelial, microglial and dopaminergic neuronal cell lines

Paz Cartas‐Cejudo, Marina De Miguel, Leire Extramiana…·Enrique Santamaría

The paper uses proteomic analysis of the olfactory tract to identify pyroxamide, an HDAC1 inhibitor, as a potential therapeutic for Parkinson's disease by reducing α-synuclein fibril-induced toxicity in cell lines.

DOI 10.1111/bpa.70140

humanproteomics

𝕏 PostBluesky

Neurosciencenpj Parkinson s DiseasePeer-reviewedAug 25, 2025

Novel in situ seeding immunodetection assay uncovers neuronal-driven alpha-synuclein seeding in Parkinson's disease

Maria Otero‐Jimenez, Marcelina J. Wojewska, Simona Jogaudaite…·Javier Alegre‐Abarrategui

The paper introduces an in situ seeding immunodetection assay to visualize alpha-synuclein and tau seeding activities with high spatial resolution in intact tissues, revealing neuron-driven alpha-synuclein seeding in Parkinson's disease before clinical symptoms.

1 citation

humanprotein structure

𝕏 PostBluesky

NeuroscienceNature GeneticsPeer-reviewedJan 10, 2025

Single-cell Mendelian randomisation identifies cell-type specific genetic effects on human brain disease and behaviour

Alexander Haglund, Verena Zuber, Maya Abouzeid…·Michael R. Johnson

The paper uses single-cell Mendelian randomisation to identify cell-type specific genetic effects on brain disease and behaviour, revealing 118 genes with causal associations to 16 brain phenotypes.

44 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky

NeuroscienceBrain CommunicationsPeer-reviewedOct 28, 2022

Common signatures of differential microRNA expression in Parkinson's and Alzheimer's disease brains

Valerija Dobričić, Marcel Schilling, Ildiko Farkas…·Christina M. Lill

The paper assesses differential microRNA expression in Parkinson's and Alzheimer's disease brains, identifying shared miRNAs with potential pathogenic roles.

23 citations

humanbulk RNA-seq

𝕏 PostBluesky